Surgical procedure for targeting arrhythmogenic substrates in the treatment of ventricular tachycardia associated with cardiac tumors.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
02 2020
Historique:
received: 22 07 2019
pubmed: 3 9 2019
medline: 28 4 2021
entrez: 3 9 2019
Statut: ppublish

Résumé

Complete tumor resection is a standard strategy in the surgical treatment of ventricular tachycardia (VT) associated with cardiac tumors. Recently, an intraoperative electroanatomic mapping system (CARTO) has enabled surgeons to target the localized arrhythmogenic substrate for partial resection and/or cryoablation in nonresectable cardiac tumors. The purpose of this study was to evaluate the surgical procedures and late outcomes of the treatment of VT associated with cardiac tumors. We examined six patients (age 1-65 years) who had undergone surgical treatment of VT associated with cardiac tumors between 2010 and 2016. The 4 pathologies of the cardiac tumors were lipoma 2, fibroma 2, hemangioma 1, and lymphoma 1. Intraoperative epicardial mapping using CARTO was performed in 5 patients(80%). Surgical procedures and long-term outcomes were evaluated. Arrhythmogenic substrates with abnormal electrograms, such as fractionated or late potential, were identified locally or circumferentially beside the tumor in every patient. Complete tumor resection with cryoablation was performed in 3 patients. Two patients underwent partial tumor resection with cryoablation. Cryoablation without tumor resection was performed in 1 patient. No mortality and morbidity occurred. Additional catheter ablation was required in 2 patients to treat occurrence of nonclinical VT and induction of clinical VT during hospital stay. Mean follow-up time was 90 ± 52.5 months. There was no recurrence of clinical VT. The outcomes of surgical treatment of VT associated with cardiac tumors were excellent. Intraoperative CARTO mapping was beneficial to eliminate the VT substrates associated with nonresectable cardiac tumors.

Sections du résumé

BACKGROUND
Complete tumor resection is a standard strategy in the surgical treatment of ventricular tachycardia (VT) associated with cardiac tumors. Recently, an intraoperative electroanatomic mapping system (CARTO) has enabled surgeons to target the localized arrhythmogenic substrate for partial resection and/or cryoablation in nonresectable cardiac tumors.
OBJECTIVE
The purpose of this study was to evaluate the surgical procedures and late outcomes of the treatment of VT associated with cardiac tumors.
METHODS
We examined six patients (age 1-65 years) who had undergone surgical treatment of VT associated with cardiac tumors between 2010 and 2016. The 4 pathologies of the cardiac tumors were lipoma 2, fibroma 2, hemangioma 1, and lymphoma 1. Intraoperative epicardial mapping using CARTO was performed in 5 patients(80%). Surgical procedures and long-term outcomes were evaluated.
RESULTS
Arrhythmogenic substrates with abnormal electrograms, such as fractionated or late potential, were identified locally or circumferentially beside the tumor in every patient. Complete tumor resection with cryoablation was performed in 3 patients. Two patients underwent partial tumor resection with cryoablation. Cryoablation without tumor resection was performed in 1 patient. No mortality and morbidity occurred. Additional catheter ablation was required in 2 patients to treat occurrence of nonclinical VT and induction of clinical VT during hospital stay. Mean follow-up time was 90 ± 52.5 months. There was no recurrence of clinical VT.
CONCLUSION
The outcomes of surgical treatment of VT associated with cardiac tumors were excellent. Intraoperative CARTO mapping was beneficial to eliminate the VT substrates associated with nonresectable cardiac tumors.

Identifiants

pubmed: 31476412
pii: S1547-5271(19)30817-3
doi: 10.1016/j.hrthm.2019.08.025
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

238-242

Informations de copyright

Copyright © 2019 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Shun-Ichiro Sakamoto (SI)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan. Electronic address: saka-165@nms.ac.jp.

Atsushi Hiromoto (A)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Hiroshige Murata (H)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Kenji Suzuki (K)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Jiro Kurita (J)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Yasuhiro Kawase (Y)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Takashi Sasaki (T)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Yasuo Miyagi (Y)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Yosuke Ishii (Y)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Tetsuro Morota (T)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Wataru Shimizu (W)

Department of Cardiovascular Medicine, Nippon Medical School, Tokyo, Japan.

Takashi Nitta (T)

Department of Cardiovascular Surgery, Nippon Medical School, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH